wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38662690-1FFCB401-FEA4-40EE-88FE-398BB55880DA
Q38662690-1FFCB401-FEA4-40EE-88FE-398BB55880DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38662690-1FFCB401-FEA4-40EE-88FE-398BB55880DA
Efficacy and safety of once-weekly semaglutide for the treatment of type 2 diabetes.
P2860
Q38662690-1FFCB401-FEA4-40EE-88FE-398BB55880DA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38662690-1FFCB401-FEA4-40EE-88FE-398BB55880DA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
253e95e6c1113c91c6d586120af1efd76de1c2ab
P2860
Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised c